XML 27 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Outstanding
Common Stock
Value of Shares Held in Rabbi Trust at Cost
Deferred Compensation and Other Retirement Benefit Obligations
Additional Paid in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     34,377,388              
Net income $ 86,526,000             $ 86,526,000    
Other comprehensive income 30,463,000                 $ 30,463,000
Cash dividends declared per common share (in dollars per share)               $ 1.38    
Common dividend declared (45,715,000)             $ (45,715,000)    
Proceeds from exercise of stock options, net of cash paid     5,873              
Proceeds from exercise of stock options, net of cash paid 114,000     $ 0     $ 114,000      
Stock based compensation 3,297,000           3,297,000      
Restricted stock awards issued, net of awards surrendered     49,249              
Restricted stock awards issued, net of awards surrendered (1,186,000)     1,000     (1,187,000)      
Shares issued under direct stock purchase plan     23,037              
Shares issued under direct stock purchase plan 1,620,000     0     1,620,000      
Stock Repurchased During Period, Shares     (1,500,000)              
Stock Repurchased During Period, Value (95,091,000)     (15,000)     (95,076,000)      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         $ 23,000 $ (23,000)        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Sep. 30, 2020 1,689,724,000     328,000 (4,712,000) 4,712,000 944,218,000 696,546,000   48,632,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method, net of tax. 817,000                  
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method [1] (1,137,000)                  
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal) (1,000,000)                  
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal), net of tax. 736,000                  
Common Stock, Shares, Outstanding     32,942,110              
Net income 34,873,000             $ 34,873,000    
Other comprehensive income (3,213,000)                 (3,213,000)
Cash dividends declared per common share (in dollars per share)               $ 0.46    
Common dividend declared (15,161,000)             $ (15,161,000)    
Proceeds from exercise of stock options, net of cash paid     5,000              
Stock Repurchased During Period, Value, as a result of Stock Options Exercised 140,000           140,000      
Stock based compensation 868,000           868,000      
Restricted stock awards issued, net of awards surrendered     (43)              
Restricted stock awards issued, net of awards surrendered (3,000)           (3,000)      
Shares issued under direct stock purchase plan     8,480              
Shares issued under direct stock purchase plan 528,000           528,000      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (63,000) 63,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Sep. 30, 2020 $ 1,689,724,000     328,000 (4,712,000) 4,712,000 944,218,000 696,546,000   48,632,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     32,955,547              
Common Stock, Shares, Outstanding 32,965,692   32,965,692              
Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) [2]   $ 1,553,000             $ 1,553,000  
Net income $ 119,290,000             $ 119,290,000    
Other comprehensive income (22,128,000)                 (22,128,000)
Cash dividends declared per common share (in dollars per share)               $ 1.44    
Common dividend declared (47,572,000)             $ (47,572,000)    
Proceeds from exercise of stock options, net of cash paid     4,744              
Stock Repurchased During Period, Value, as a result of Stock Options Exercised 57,000           57,000      
Stock based compensation 3,467,000           3,467,000      
Restricted stock awards issued, net of awards surrendered     53,795              
Restricted stock awards issued, net of awards surrendered (1,246,000)     1,000     (1,247,000)      
Shares issued under direct stock purchase plan     19,581              
Shares issued under direct stock purchase plan 1,515,000           1,515,000      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (91,000) 91,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Sep. 30, 2021 1,755,954,000     329,000 (3,157,000) 3,157,000 949,316,000 787,742,000   18,567,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     33,037,859              
Net income 40,007,000             $ 40,007,000    
Other comprehensive income (11,000,000)                 (11,000,000)
Cash dividends declared per common share (in dollars per share)               $ 0.48    
Common dividend declared (15,861,000)             $ (15,861,000)    
Stock based compensation 707,000           707,000      
Restricted stock awards issued, net of awards surrendered     (763)              
Restricted stock awards issued, net of awards surrendered (3,000)           (3,000)      
Shares issued under direct stock purchase plan     6,716              
Shares issued under direct stock purchase plan 482,000           482,000      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (41,000) 41,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Sep. 30, 2021 $ 1,755,954,000     $ 329,000 $ (3,157,000) $ 3,157,000 $ 949,316,000 $ 787,742,000   $ 18,567,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding 33,043,812   33,043,812              
[1] Represents adjustment needed to reflect the cumulative day one impact pursuant to the Company's adoption of Accounting Standards Update 2016-13. The adjustment represents a $1.1 million decrease to the allowance attributable to the change in accounting methodology for estimating the allowance for credit losses resulting from the Company's adoption of the standard.
[2] Represents adjustment needed to reflect the cumulative impact on retained earnings pursuant to the Company's adoption of Accounting Standards Update 2016-13. The adjustment presented includes $1.1 million ($817,000, net of tax) attributable to the change in accounting methodology for estimating the allowance for credit losses and $1.0 million ($736,000, net of tax) related to the reserve for unfunded commitments resulting from the Company's adoption of the standard. Amount shown in the table above is presented net of tax.